WOLVERINE
- ≥99% purity by HPLC
- Janoshik COA with every lot
- Lot-traceable from synthesis
- EU-synthesised
Specifications
Third Party Lab Tested
Every lot is independently HPLC-tested by Janoshik Analytical, Europe's reference laboratory for peptide purity assessment. The COA shipped with your order is theirs, not ours.
Storage & Handling
Lyophilized peptides should be stored below 16°C, protected from light and moisture, for up to 24 months. Once reconstituted, refrigerate and use within 30 days for protocol consistency.
Reconstitution
Reconstitute with bacteriostatic water using the volumes below. Add solvent slowly along the inside wall of the vial. Swirl gently, never shake, until fully dissolved.
Lab-handling protocol BAC Water · 0.9% benzyl alcohol The reconstitution solvent referenced above. Add to order →Two pathways,
one stack.
WOLVERINE pairs two of the most-cited tissue-repair peptides in the recovery literature. BPC-157 is a stable gastric pentadecapeptide with documented effects on tendon, ligament, and gut tissue models. TB-500 (a synthetic Thymosin β-4 fragment) modulates actin sequestration and has well-characterized effects on cell migration and angiogenesis.
Used together at a 1:1 ratio, the blend covers complementary repair mechanisms - vascular and structural. It is the most replicable starting point for any recovery-focused research protocol.
| Compound 1 | BPC-157 |
|---|---|
| Molecular mass | 1419.5 Da |
| Mechanism / research class | Pentadecapeptide. Sequence: GEPPPGKPADDAGLV. Stable in gastric juice. |
| Compound 2 | TB-500 |
| Sequence length | 17 amino acids |
| Molecular mass | 1888.2 Da |
| Mechanism / research class | Thymosin β-4 fragment. Actin-sequestering activity. |
| Lab handling solvent | 2mL bacteriostatic water for injection (BWI) |
| Resulting concentration | Yields 0.5mg per 0.1mL combined |
| Supply format | · 10MG BLEND: BPC-157 5MG · TB-500 5MG lyophilized research vial |
| Storage, lyophilized | store below 16°C for up to 24 months |
| Storage, reconstituted | refrigerate and use within 30 days |
Synthesised.
Verified.
Documented.
Backed by research.
Measured in results.
Each tag opens the cited literature behind that effect. References are linked to PubMed.
WOLVERINE pairs BPC-157's structural-protection profile with TB-500's actin-sequestration / migration profile. The combined-mechanism stack is the most-cited starting point in published recovery-protocol research, with documented effects on tendon, ligament, and gut-tissue repair models.
TB-500's actin-sequestration mechanism modulates endothelial cell migration and angiogenic response. Combined with BPC-157's vascular effects, the blend addresses both structural and vascular repair pathways in parallel.
- Sosne G et al. Thymosin β4 promotes angiogenesis. Ann NY Acad Sci. 2010;1194:114-118. PubMed ↗
Both compounds individually show anti-inflammatory activity in research models. BPC-157's literature includes direct effects on NO-pathway and prostaglandin signaling; TB-500 modulates inflammatory-cell recruitment via actin-cytoskeleton effects.
- Sikiric P et al. BPC-157 and inflammation. Curr Pharm Des. 2018;24(18):1990-2001. PubMed ↗
Questions?
We got answers.
Show references
Used in published research.
4.9 / 5
Solid product, fast EU shipping
Ordered WOLVERINE for a research-protocol pilot. Arrived in 4 days temperature-controlled, vials sealed and properly lyophilized. Reconstituted cleanly in BWI with no haze. Will reorder.
